New Data Presented at the American Psychiatric Association Annual Meeting May Shape the Standard of Care for Bipolar Disorder NEW YORK, May 5 /PRNewswire/ -- "These preliminary findings should shape the standard of care for bipolar disorder going forward," says Joseph Calabrese, MD, co-Director of the National Institute of Mental Health Bipolar Research Center at University Hospitals of Cleveland and Case Western Reserve University. The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms. For the first time, researchers have demonstrated in separate short-term trials that a single drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder. Dr. Calabrese will present these data at the annual meeting of the American Psychiatric Association in New York City on Wednesday, May 5 beginning at 3pm. ADDITIONAL RESOURCES: Video version and more available at http://www.prnewswire.com/broadcast/12208/consumer.shtml SOUNDBITES: Joseph Calabrese, MD, Co-Director of the National Institute of Mental Health Bipolar Research Center at University Hospitals of Cleveland and Case Western Reserve University. VIDEO PROVIDED BY: AstraZeneca http://www.prnewswire.com/broadcast/12208/consumer.shtmlDATASOURCE: AstraZeneca CONTACT: MultiVu Media Relations, 1-800-653-5313, ext. 3, for AstraZeneca Web site: http://www.multivu.com/

Copyright